Quebec-based Quantum eMotion’s partner, Greybox Solutions, has produced successful results in testing its digital therapeutics platform (DTx) for heart failure patients. The study, in collaboration with several other partners, revealed a decrease in healthcare costs and hospital visits. Quantum eMotion’s CEO, Francis Bellido, highlighted the importance of robust cybersecurity in protecting patient data and praised Greybox’s partners for their contributions to the study.
NHS England faces lawsuit over patient privacy fears linked to new data platform | NHS
Four organisations are suing NHS England over the legality of its Federated Data Platform (FDP), designed to allow easier sharing of patient information to improve
